<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00775801</url>
  </required_header>
  <id_info>
    <org_study_id>PR-125</org_study_id>
    <nct_id>NCT00775801</nct_id>
  </id_info>
  <brief_title>Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease</brief_title>
  <acronym>FLD</acronym>
  <official_title>An IDE Study of the Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AxioMed Spine Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AxioMed Spine Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will look at the result of using the FLD device as an artificial lumbar disc. The&#xD;
      study will compare the safety and effectiveness of the FLD artificial lumbar disc to an&#xD;
      already approved artificial lumbar disc.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Freedom Lumbar Disc is indicated for spinal arthroplasty in skeletally mature patients&#xD;
      with single level, symptomatic degenerative disc disease (DDD) from L3-S1. This is a&#xD;
      prospective, multi-center, randomized, controlled trial. Subjects with DDD will be randomized&#xD;
      to disc arthroplasty with the FLD device or a control device. The overall purpose (objective)&#xD;
      of this trial is to collect clinical data to demonstrate the safety and effectiveness of FLD&#xD;
      used for the treatment of symptomatic lumbar degenerative disc disease compared to the&#xD;
      control device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall success will be determined by a composite of measures regarding subject self-assessment of function (disability), low back pain, neurological function and device implantation status.</measure>
    <time_frame>24 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The improvement of subject self-assessment of function (disability), low back pain, patient satisfaction, neurological function and device implantation status at the 24 month follow-up compared to baseline.</measure>
    <time_frame>24 Months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Degenerative Disc Disease (DDD)</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FLD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FLD</intervention_name>
    <description>Artificial lumbar disc</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Artificial lumbar disc</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Single level, degenerative disc disease at L3 to S1, inclusive.&#xD;
&#xD;
          -  Minimum of 6 months of unsuccessful conservative treatment.&#xD;
&#xD;
          -  Subject is a surgical candidate for an anterior approach to the lumbar spine (&lt;3&#xD;
             abdominal surgeries).&#xD;
&#xD;
          -  Back pain at the operative level only (by discogram, if necessary).&#xD;
&#xD;
          -  Leg pain and/or back pain due to disc space settling, with or without radicular&#xD;
             symptoms related to foraminal narrowing.&#xD;
&#xD;
          -  Subject must understand and sign the written Informed Consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior fusion at any lumbar level.&#xD;
&#xD;
          -  Clinical evidence of adjacent lumbar segment disease.&#xD;
&#xD;
          -  Previous trauma to the L3, L4, L5, or S1 levels (in compression or burst).&#xD;
&#xD;
          -  Non-contained or extruded herniated nucleus pulposus.&#xD;
&#xD;
          -  Congenital stenosis or central/lateral stenosis (mid-sagittal stenosis of &lt;8mm by CT&#xD;
             or MR) secondary to acquired degenerative disease requiring treatment that&#xD;
             destabilizes the spine (requiring fusion), or for subjects in whom increased motion&#xD;
             may increase symptoms.&#xD;
&#xD;
          -  Retro- or spondylolisthesis of ≥ 2.5 mm which is either fixed or present on&#xD;
             flexion/extension films, and slippage of vertebral body where the listhesis is due to&#xD;
             disc space settling in the absence of degenerative facets or a pars interarticularis&#xD;
             defect.&#xD;
&#xD;
          -  Significant kyphosis (&gt;11ْ sagittal plane deformity).&#xD;
&#xD;
          -  History of any invasive malignancy (except non-melanoma skin cancer) unless treated&#xD;
             with curative intent and there have been no clinical signs or symptoms of malignancy&#xD;
             for at least 5 years (in particular, spinal tumors).&#xD;
&#xD;
          -  Acute or chronic infection (local or systemic).&#xD;
&#xD;
          -  Instability or facet joint arthrosis, clinically significant.&#xD;
&#xD;
          -  Arachnoiditis.&#xD;
&#xD;
          -  Known or suspected allergy to titanium, polyurethane, cobalt, chromium, molybdenum or&#xD;
             silicone.&#xD;
&#xD;
          -  Radiographic findings of a fused or total collapsed disc.&#xD;
&#xD;
          -  Subject using medications or drugs known to potentially interfere with bone or soft&#xD;
             tissue healing (high-dose of steroids, osteoclast inhibitors, etc.).&#xD;
&#xD;
          -  Systemic disease affecting the spine, including rheumatoid arthritis, autoimmune&#xD;
             disease, AIDS, HIV, or hepatitis.&#xD;
&#xD;
          -  Paget's disease, osteomalacia or any other metabolic bone disease (excluding&#xD;
             osteoporosis which is addressed separately).&#xD;
&#xD;
          -  Psychosocial disorders (e.g. evidence or drug or alcohol abuse).&#xD;
&#xD;
          -  Morbid (extreme) obesity (BMI ≥ 40 kg/m2).&#xD;
&#xD;
          -  Bone growth stimulator use in spine.&#xD;
&#xD;
          -  Investigational drug or device use within 30 days.&#xD;
&#xD;
          -  Osteoporosis or osteopenia or metabolic bone disease as confirmed by DEXA scan if poor&#xD;
             bone quality is suspected (T-score &lt; -1.0).&#xD;
&#xD;
          -  If female of childbearing potential, pregnant or interested in becoming pregnant in&#xD;
             the next three years.&#xD;
&#xD;
          -  Type 1 diabetes, and uncontrolled (or poorly controlled) Type 2 diabetes.&#xD;
&#xD;
          -  Subjects with a history of implant rejection.&#xD;
&#xD;
          -  Provocative discography with non-concordant pain at the operative level.&#xD;
&#xD;
          -  Incarcerated subjects.&#xD;
&#xD;
          -  Myelopathy.&#xD;
&#xD;
          -  Significant leg pain of a radicular or neurogenic claudication nature.&#xD;
&#xD;
          -  Involved vertebral endplates dimensionally smaller then 39 mm in the mediallateral&#xD;
             and/or 32 mm in the anterior-posterior directions.&#xD;
&#xD;
          -  Subjects not able to meet follow-up requirements.&#xD;
&#xD;
          -  Lumbar scoliosis &gt; 11 degrees.&#xD;
&#xD;
          -  Any previous or current litigation related to the spine.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CORE Orthopaedic Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Spine Institute</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Resurgens Spine Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska Spine Center, LLC</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU/Hospital for Joint Diseases</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina NeuroSurgery &amp; Spine Associates</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Orthopaedic Associates, P.A.</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Spine Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Back Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>76208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gordon Spine &amp; Brain Associates</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westend Hospital</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum-Goerlitz</name>
      <address>
        <city>Gorlitz</city>
        <zip>02828</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.axiomed.com</url>
    <description>AxioMed's Website</description>
  </link>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>October 13, 2008</study_first_submitted>
  <study_first_submitted_qc>October 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2008</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

